TGFB2 and colon adenocarcinoma: We found that the expression of TGFβ2 was significantly elevated relative to normal controls in cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD) and thyroid carcinoma (THCA).